Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Freya Meds vs TeleFirst Med

Freya Meds
Graded #364

Higher grade

vs+1.2000000000000028
TeleFirst Med
Graded #400

Lower grade

The verdict

Freya Meds takes it — 58.6/100 to 57.4/100, but only just.

Freya Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo). TeleFirst Med is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleFirst Med +2
43
45
Dose & formulationFreya Meds +11
64
53
Clinical oversightTeleFirst Med +11
71
82
Labs & monitoringFreya Meds +8
60
52
FulfillmentFreya Meds +4
62
58
Contract termsEven
55
55
Freya Meds · left barTeleFirst Med · right bar

The numbers

MetricFreya MedsTeleFirst Med
WeighScore58.6/10057.4/100
GradeCC
Scorecard rank#364#400
Semaglutide$297/mo (compounded)Not disclosed
Tirzepatide$390/mo (compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Freya Meds

Graded #364 · C

Strengths

  • GLP-1 specialist — not a multi-category telehealth
  • Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
  • Both semaglutide and tirzepatide available
  • Multi-month discount on quarterly billing
  • Claims 450,000+ enrolled

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Above-average pricing ($250–$390/mo)
  • Compounded only — no brand-name options
  • Now serves 49 U.S. states (one state excluded; specific exclusion not named)
TeleFirst Med

Graded #400 · C

Strengths

  • Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
  • Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
  • You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
  • Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care

Where it loses points

  • Only Texas and North Carolina are confirmed — not available nationwide
  • The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
  • Small practice (about 500 patients) with limited public detail on its clinicians and program
  • No compounded or lower-cost medication option, and no medication pricing is published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard